Evaluation of the role of breast cancer resistance protein (BCRP/ABCG2) and multidrug resistance-associated protein 4 (MRP4/ABCC4) in the urinary excretion of sulfate and glucuronide metabolites of edaravone (MCI-186; 3-methyl-1-phenyl-2-pyrazolin-5 (Q40097205)
Jump to navigation
Jump to search
scientific article published on 6 August 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Evaluation of the role of breast cancer resistance protein (BCRP/ABCG2) and multidrug resistance-associated protein 4 (MRP4/ABCC4) in the urinary excretion of sulfate and glucuronide metabolites of edaravone (MCI-186; 3-methyl-1-phenyl-2-pyrazolin-5 |
scientific article published on 6 August 2007 |
Statements
1 reference
Evaluation of the role of breast cancer resistance protein (BCRP/ABCG2) and multidrug resistance-associated protein 4 (MRP4/ABCC4) in the urinary excretion of sulfate and glucuronide metabolites of edaravone (MCI-186; 3-methyl-1-phenyl-2-pyrazolin-5 (English)
1 reference
Naomi Mizuno
1 reference
Tsuyoshi Takahashi
1 reference
Hiroyuki Kusuhara
1 reference
John D Schuetz
1 reference
Takuro Niwa
1 reference
Yuichi Sugiyama
1 reference
6 August 2007
1 reference
1 reference
Identifiers
1 reference